(I-O) Multilevel atherosclerosis in 56 years old famale dr n. med. Hanna Dziedzic-Oleksy dr n. med. Monika Komar dr n. med. Łukasz Tekieli prof. dr hab. med. Piotr Pieniążek prof. dr hab. med. Piotr Podolec

 

BRIEF COMMENTS

EXPERT: Prof. Egle Ereminiene MD, PhD
Affiliation: Hospital of Lithuanian University of Health Sciences, Kaunas
COMMENT
At this point further conservative treatment seems the right choice. After intervention on carotid artery clopidogrel should be administered. Scintigraphy is essential to estimate ischemic region in the heart. Considering peripheral artery disease – exercise training aimed at improving the walking distance is necessary. Cilostazol do not improve prognosis, only symptoms, but our experience with this treatment is limited.

EXPERT: Prof. Henryk Siniawski MD, PhD
Affiliation: Deutsches Herzzentrum, Berlin, Germany
COMMENT
Risk factors should be revised, especially any hormonal therapy must be discontinued. Interventional revascularisation followe by aspirin and clopidogrel therapy is essential. Indications for ticaglerol use should be considered. Exercise training will improve her symptoms. Risk factors reduction is needed.

EXPERT: Jakub Podolec MD, PhD
Affiliation: Department of Hemodynamics, John Paul II Hospital, Krakow
COMMENT
Such advanced atherosclerosis in young female may have genetic background. Now she needs cardiac ischemia assessment and revascularizations in the future.

CONCLUSIONS

1) Revascularization will be indicated in the future
2) Heart ischemia assessment – scintigraphy
3) Exercise training, drugs: aspirin and clopidogrel, maybe ticaglerol administration
4) Revised all risk factors


“Development of the European Network in Orphan Cardiovascular Diseases”
„Rozszerzenie Europejskiej Sieci Współpracy ds. Sierocych Chorób Kardiologicznych”

This entry was posted in Case presentations, I. Rare diseases of systemic circulation, Others. Bookmark the permalink.

Comments are closed.